MAGEA3 and ovarian carcinoma: Positive expression of MAGE-1 and MAGE-3 was positively correlated with the pathological grade and clinical stage of ovarian cancer patients (P < 0.05), while positive expression of MAGE-1 and MAGE-3 was not related to pathological grade and clinical stage (P > 0.05).